These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17893562)

  • 1. Gene transfer of noncleavable cell surface mutants of human CD154 induces the immune response and diminishes systemic inflammatory reactions.
    Masuta Y; Kato K; Tomihara K; Nakamura K; Sasaki K; Takahashi S; Hamada H
    J Immunother; 2007 Oct; 30(7):694-704. PubMed ID: 17893562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG oligodeoxynucleotides enhance the capacity of adenovirus-mediated CD154 gene transfer to generate effective B-cell lymphoma vaccines.
    Rieger R; Kipps TJ
    Cancer Res; 2003 Jul; 63(14):4128-35. PubMed ID: 12874017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells.
    Li LH; Biagi E; Allen C; Shivakumar R; Weiss JM; Feller S; Yvon E; Fratantoni JC; Liu LN
    Cancer Gene Ther; 2006 Feb; 13(2):215-24. PubMed ID: 16082377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells.
    Tomihara K; Kato K; Masuta Y; Nakamura K; Uchida H; Sasaki K; Tanaka T; Huang J; Hiratsuka H; Hamada H
    Gene Ther; 2008 Feb; 15(3):203-13. PubMed ID: 17989706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for CD40-directed experimental therapy of human cancer.
    Tong AW; Stone MJ
    Cancer Gene Ther; 2003 Jan; 10(1):1-13. PubMed ID: 12489023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.
    Battle TE; Wierda WG; Rassenti LZ; Zahrieh D; Neuberg D; Kipps TJ; Frank DA
    Clin Cancer Res; 2003 Jun; 9(6):2166-72. PubMed ID: 12796382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD154 gene therapy for human B-cell malignancies.
    Messmer D; Kipps TJ
    Ann N Y Acad Sci; 2005 Dec; 1062():51-60. PubMed ID: 16461788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein.
    Cantaluppi V; Deregibus MC; Biancone L; Deambrosis I; Bussolati B; Albini A; Camussi G
    Int J Immunopathol Pharmacol; 2006; 19(1):81-96. PubMed ID: 16569346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet-associated CD154: a new interface in haemostasis and in the inflammatory reaction].
    Delmas Y; Viallard JF; Villeneuve J; Grosset C; Pasquet JM; Déchanet-Merville J; Nurden P; Pellegrin JL; Rosenbaum J; Combe C; Nurden AT; Ripoche J
    Med Sci (Paris); 2005 Oct; 21(10):825-31. PubMed ID: 16197899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI; Manea EM
    Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.
    Kato K; Cantwell MJ; Sharma S; Kipps TJ
    J Clin Invest; 1998 Mar; 101(5):1133-41. PubMed ID: 9486984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the number of CD154 molecules in membrane extracts used as a source of CD40 stimulation of human B lymphocytes.
    Ducas E; Dussault N; Roy A; Dumont N; Néron S
    J Immunol Methods; 2009 May; 344(2):133-7. PubMed ID: 19332074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of natural human antagonistic soluble CD40 isoforms produced through alternative splicing.
    Eshel D; Toporik A; Efrati T; Nakav S; Chen A; Douvdevani A
    Mol Immunol; 2008 Dec; 46(2):250-7. PubMed ID: 18849075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD40-CD154 interaction in tissue fibrosis.
    Kawai M; Masuda A; Kuwana M
    Arthritis Rheum; 2008 Nov; 58(11):3562-73. PubMed ID: 18975310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].
    Zhang J; Chen GH; Weng JP; Lu MQ; Yang Y; Cai CJ; Xu C; Li H
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):136-9. PubMed ID: 18509975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic therapy for B-cell malignancies.
    Kipps TJ; Chu P; Wierda WG
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):104-9. PubMed ID: 11225994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
    Gregory MS; Saff RR; Marshak-Rothstein A; Ksander BR
    Cancer Res; 2007 Dec; 67(24):11951-8. PubMed ID: 18089826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis.
    Ishikawa K; Miyamoto M; Yoshioka T; Kato T; Kaji M; Ohbuchi T; Hirano S; Itoh T; Dosaka-Akita H; Kondo S
    Cancer; 2008 Aug; 113(3):530-41. PubMed ID: 18548529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.